Bruce Braswell
Medical · Sikeston, MONPI 1619066024
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,852 of the $6,504 with a category attached, or 90.0%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.
Across 245 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$729
- Paratek Pharmaceuticals, Inc.$652
- AstraZeneca$620
- Lilly USA, LLC$541
- plus $2K from 19 others
What the payments were for
- Consulting fees$64010%
- Food & beverage$5,85290%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,407 |
| Novo Nordisk | 27 | $1,039 |
| Boehringer Ingelheim | 32 | $729 |
| Paratek Pharmaceuticals, Inc. | 2 | $652 |
| AstraZeneca | 19 | $620 |
| Lilly USA, LLC | 26 | $541 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $306 |
| Axsome Therapeutics, Inc. | 3 | $176 |
| Mylan Specialty L.p. | 9 | $154 |
| Pfizer | 8 | $135 |
| Amgen | 1 | $107 |
| Esperion Therapeutics, Inc. | 6 | $96 |
| Novartis | 5 | $96 |
| Lundbeck LLC | 5 | $94 |
| Biohaven Pharmaceuticals, Inc. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Almatica Pharma LLC | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Bayer | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Philips North America LLC | 1 | $16 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,504 in reported general payments places this provider in the 85th percentile of 198 medical providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 144 | $118,254 |
| JardianceEmpagliflozin | 68 | $73,101 |
| TrulicityDulaglutide | 46 | $63,907 |
| XifaxanRifaximin | 13 | $42,214 |
| MounjaroTirzepatide | 34 | $39,515 |
| OzempicSemaglutide | 25 | $24,567 |
| FarxigaDapagliflozin Propanediol | 18 | $23,065 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $15,467 |
| TradjentaLinagliptin | 19 | $13,771 |
| EntrestoSacubitril/Valsartan | 20 | $12,360 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $11,016 |
| RybelsusSemaglutide | 12 | $10,959 |
| LinzessLinaclotide | 20 | $10,560 |
| XareltoRivaroxaban | 15 | $7,252 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $4,814 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $135 | $118,254144 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $541 | $104,26393 claims |
| Boehringer IngelheimJardiance, Tradjenta | $729 | $86,87187 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $306 | $42,21413 claims |
| Novo NordiskOzempic, Rybelsus | $1,039 | $35,52637 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $620 | $34,08133 claims |
| NovartisEntresto | $96 | $12,36020 claims |
| AbbVieLinzess | $1,407 | $10,56020 claims |
| Johnson & JohnsonXarelto | $19 | $7,25215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 198 medical providers in Missouri.
Other medical in Sikeston
- Amy FolsomSikeston$6K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
- Corey WhitesidesColumbia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.